bit.ly
Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas | EMBO Molecular Medicine
imageimageADAM12, a disintegrin and metalloprotease, is expressed in cancer-associated fibroblasts
(CAFs) and tumor cells in pancreatic ductal adenocarcinoma (PDAC). Using both subcutaneous
and orthot...